For decades, pharmaceutical giant Johnson and Johnson sold its popular talcum powder in the US, Canada, the UK, India and globally as an antidote to skin irritation or nappy rash after bathing.

Strengthens focus of Johnson & Johnson (JNJ) as an innovation powerhouse and accelerates the portfolio shift of its MedTech Segment to higher-growth and higher-margin markets Standalone orthopaedics ...

Johnson & Johnson is currently overvalued, with limited upside and mid-to-high single-digit long-term return potential amid ongoing sector risks. Despite solid recent earnings and raised guidance, JNJ ...

The case involves a California woman who died from mesothelioma, a rare cancer. Her family claimed Johnson and Johnson’s talc powder products were to blame. By Kailyn Rhone A Los Angeles jury ordered ...